These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38301954)

  • 1. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
    Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
    SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
    Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13.
    Soper N; Yardumian I; Chen E; Yang C; Ciervo S; Oom AL; Desvignes L; Mulligan MJ; Zhang Y; Lupoli TJ
    ACS Chem Biol; 2024 Jul; 19(7):1593-1603. PubMed ID: 38980755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
    Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L
    Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
    Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA.
    Jang KJ; Jeong S; Kang DY; Sp N; Yang YM; Kim DE
    Sci Rep; 2020 Mar; 10(1):4481. PubMed ID: 32161317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors.
    Yazdi AK; Pakarian P; Perveen S; Hajian T; Santhakumar V; Bolotokova A; Li F; Vedadi M
    ACS Infect Dis; 2022 Aug; 8(8):1533-1542. PubMed ID: 35822715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.
    Grimes SL; Choi YJ; Banerjee A; Small G; Anderson-Daniels J; Gribble J; Pruijssers AJ; Agostini ML; Abu-Shmais A; Lu X; Darst SA; Campbell E; Denison MR
    mBio; 2023 Aug; 14(4):e0106023. PubMed ID: 37338298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
    Zheng T; Shen B; Bai Y; Li E; Zhang X; Hu Y; Gao T; Dong Q; Zhu L; Jin R; Shi H; Liu H; Gao Y; Liu X; Cao C
    J Virol; 2024 Apr; 98(4):e0156523. PubMed ID: 38445884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput screening for SARS-CoV-2 helicase inhibitors.
    Otsuka Y; Kim E; Krueger A; Shumate J; Wang C; Bdiri B; Ullah S; Park H; Scampavia L; Bannister TD; Chung D; Spicer TP
    SLAS Discov; 2024 Sep; 29(6):100180. PubMed ID: 39173831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical analysis of SARS-CoV-2 Nsp13 helicase implicated in COVID-19 and factors that regulate its catalytic functions.
    Sommers JA; Loftus LN; Jones MP; Lee RA; Haren CE; Dumm AJ; Brosh RM
    J Biol Chem; 2023 Mar; 299(3):102980. PubMed ID: 36739951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
    Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Coronavirus helicase in replication.
    Grimes SL; Denison MR
    Virus Res; 2024 Aug; 346():199401. PubMed ID: 38796132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations.
    Di Paco G; Macchiagodena M; Procacci P
    ChemMedChem; 2024 May; 19(10):e202400095. PubMed ID: 38456332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
    Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X
    Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.
    Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SE; Aher A; Liu S; Kapoor TM
    Biophys J; 2021 Mar; 120(6):1020-1030. PubMed ID: 33340543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication.
    Corona A; Madia VN; De Santis R; Manelfi C; Emmolo R; Ialongo D; Patacchini E; Messore A; Amatore D; Faggioni G; Artico M; Iaconis D; Talarico C; Di Santo R; Lista F; Costi R; Tramontano E
    Antiviral Res; 2023 Sep; 217():105697. PubMed ID: 37562607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
    Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase.
    Zhang C; Yu J; Deng M; Zhang Q; Jin F; Chen L; Li Y; He B
    Molecules; 2024 May; 29(10):. PubMed ID: 38792162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.